Several different therapies, including steroids, IL-6-inhibitors, JAK-inhibitors, IL-1 receptor antagonists, and TNF-α inhibitors, have been reported to be beneficial in the treatment of selected groups with COVID-19. This evidence concerns the gene IL6 and COVID-19.